Education
PhD, Johns Hopkins Bloomberg School of Public Health, 2008
MHS, Johns Hopkins Bloomberg School of Public Health, 2006
MS, Harvard School of Public Health, 2003
MS, National Yang-Ming University, 1997
BS, National Taiwan University, 1995
Overview
Risk adjustment and its applications
Pharmacoepidemiology
Overuse measurements and their applications
Outcome evaluation and cost-effectiveness analysis
Honors and Awards
Phi Beta Kappa Honor Society, 2009-Present
Taiwan Merits Scholarships, 2005–2008
Rotary Foundation Academic-Year Ambassadorial Scholar, 2001–2002
Selected publications from the last two years.
- Chang HY, Singh S, Mansour O, et al. Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes. (Published online: Aug 2018 JAMA Intern Med)
https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2696730
- Chang HY, Kharrazi H, Bodycombe D, et al. Healthcare costs and utilization associated with high-risk prescription opioid use. BMC Medicine. 2018:16:69.
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-018-1058-y
- Chang HY, Murimi I, Mark F, et al. Impact of prescription drug monitoring programs and pill mill laws on high-risk patients. Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):422-429.
https://onlinelibrary.wiley.com/doi/abs/10.1002/pds.4404
- Chang HY, Murimi I, Jones C, Alexander GC. Relationship Between High-Risk Patients Receiving Prescription Opioids and High-Volume Opioid Prescribers. Addiction. 2018 Apr;113(5):677-686
https://onlinelibrary.wiley.com/doi/abs/10.1111/add.14068
- Chang HY, Richards TM, Shermock KM, et al. Evaluating the Impact of Prescription Fill Rates on Risk Stratification Model Performance. Med Care. 2017 Dec;55(12):1052-1060.
https://insights.ovid.com/pubmed?pmid=29036011
See all publications by Hsien-Yen Chang
